LifeStance Health Group, Inc.LFSTEarnings & Financial Report
Lifestance Health (Lifestance) is an American outpatient behavioral health services provider. They provide their services in person and via tele-health. Their services include therapy, psychiatry, TMS, and ketamine therapies. They have landed in lawsuits multiple times over labor violations, leaking of customer information, and misleading investors.
LFST Q3 2025 Key Financial Metrics
Revenue
$363.8M
Gross Profit
N/A
Operating Profit
$7.4M
Net Profit
$1.1M
Gross Margin
N/A
Operating Margin
2.0%
Net Margin
0.3%
YoY Growth
16.3%
Financial Flow
LifeStance Health Group, Inc. Q3 2025 Financial Summary
LifeStance Health Group, Inc. reported revenue of $363.8M for Q3 2025, with a net profit of $1.1M (0.3% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $363.8M |
|---|---|
| Net Profit | $1.1M |
| Gross Margin | N/A |
| Operating Margin | 2.0% |
| Report Period | Q3 2025 |
LifeStance Health Group, Inc. Annual Revenue by Year
LifeStance Health Group, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $1.3B).
| Year | Annual Revenue |
|---|---|
| 2024 | $1.3B |
| 2023 | $1.1B |
| 2022 | $859.5M |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $280.6M | $300.4M | $312.3M | $312.7M | $325.5M | $333.0M | $345.3M | $363.8M |
| YoY Growth | 22.3% | 18.9% | 20.3% | 19.0% | 16.0% | 10.8% | 10.6% | 16.3% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $2.11B | $2.11B | $2.12B | $2.11B | $2.12B | $2.10B | $2.15B | $2.15B |
| Liabilities | $681.0M | $677.3M | $689.3M | $670.8M | $672.0M | $647.6M | $672.9M | $656.2M |
| Equity | $1.43B | $1.43B | $1.43B | $1.44B | $1.45B | $1.46B | $1.47B | $1.49B |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $16.8M | $-21.8M | $44.1M | $22.7M | $62.3M | $-3.1M | $64.4M | $27.3M |
